Doug Levinson is the co-founder and CEO of Fount Bio, a Somerville, Massachusetts life science company building Flī-HA, a platform to deliver long-lasting hyaluronic acid into skin through topical application rather than injection. A serial life-sciences entrepreneur with a Harvard PhD in genetics, Levinson has spent roughly 25 years founding and running companies across diagnostics, aesthetics, and drug delivery, including Cytrellis Biosystems, T2 Biosystems, and YourBio Health, after early stints at Millennium Pharmaceuticals and TransForm Pharmaceuticals and a partner role at Flagship Ventures.
Irina Erenburg is the founder, president and CEO of AVAVA, a Waltham, Massachusetts medical aesthetics company behind MIRIA, a new class of dermatology laser built on the company's proprietary Focal Point Technology. A biomedical scientist turned serial entrepreneur, she earned a PhD from the Mount Sinai School of Medicine and got her start negotiating high-value deals inside Boston's largest hospital network, where she helped shepherd startups including Zeltiq Aesthetics. She has co-founded R2 Dermatology and Soltego and, in 2024, raised $35 million to commercialize AVAVA's technology for treating skin of every tone.